Xenografted human iPSC-derived neurons with the familial Alzheimer’s disease APPV717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator
Acta Neuropathologica · 2024-06 · 147 (1)
DOI: 10.1007/s00401-024-02755-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 25.06.2024. Verfasst von Wenhui Qu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Presbyterian Hospital, Columbia University, 650W 168th Street, New York, NY, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Alzheimer Disease, Neurons, Transcriptome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thompson Family Foundation, NINDS NIH HHS, NIGMS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common cause of dementia, and disease mechanisms are still not fully understood. Here, we explored pathological changes in human induced pluripotent stem cell (iPSC)-derived neurons carrying the familial AD APP V717I mutation after cell injection into the mouse forebrain. APP V717I mutant iPSCs and isogenic controls were differentiated into neurons revealing enhanced Aβ 42 production, elevated phospho-tau, and impaired neurite outgrowth in APP V717I neurons. Two months after transplantation, APP V717I and control neural cells showed robust engraftment but at 12 months post-injection, APP V717I grafts were smaller and demonstrated impaired neurite outgrowth compared to controls, while plaque and tangle pathology were not seen. Single-nucleus RNA-sequencing of micro-dissected grafts, performed 2 months after cell injection, identified significantly altered transcriptome signatures in APP V717I iPSC-derived neurons pointing towards dysregulated synaptic function and axon guidance. Interestingly, APP V717I neurons showed an increased expression of genes, many of which are also upregulated in postmortem neurons of AD patients including the transmembrane protein LINGO2. Downregulation of LINGO2 in cultured APP V717I neurons rescued neurite outgrowth deficits and reversed key AD-associated transcriptional changes related but not limited to synaptic function, apoptosis and cellular senescence. These results provide important insights into transcriptional dysregulation in xenografted APP V717I neurons linked to synaptic function, and they indicate that LINGO2 may represent a potential therapeutic target in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Cell Biology, Presbyterian Hospital, Columbia University, 650W 168th Street, New York, NY, USA.
- Department of Neurology, Center for Translational and Computational Neuroimmunology, Neurological Institute, Columbia University, 710 West 168th Street, New York, NY, USA.
- Department of Neurosurgery, Columbia University, New York, NY, USA.
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
- Department of Neurology, Center for Translational and Computational Neuroimmunology, Neurological Institute, Columbia University, 710 West 168th Street, New York, NY, USA. vm2545@cumc.columbia.edu.
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA. vm2545@cumc.columbia.edu.
ORCID-Profile: Gunnar Hargus
Förderung
- Thompson Family Foundation
- NINDS NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- Henry and Marilyn Taub Foundation
Zitieren
APA
Qu, W., Lam, M., McInvale, J. J., Mares, J. A., Kwon, S., Humala, N., Mahajan, A., Nguyen, T., Jakubiak, K. A., Mun, J. Y., Tedesco, T. G., Al-Dalahmah, O., Hussaini, S. A., Sproul, A. A., Siegelin, M. D., De Jager, P. L., Canoll, P., Menon, V., & Hargus, G. (2024). Xenografted human iPSC-derived neurons with the familial Alzheimer’s disease APPV717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-024-02755-5
Vancouver
Qu W, Lam M, McInvale JJ, Mares JA, Kwon S, Humala N, et al. Xenografted human iPSC-derived neurons with the familial Alzheimer’s disease APPV717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator. Acta Neuropathologica. 2024;147(1). doi:10.1007/s00401-024-02755-5
BibTeX
@article{Qu2024,
author = {Qu, Wenhui and Lam, Matti and McInvale, Julie J and Mares, Jason A and Kwon, Sam and Humala, Nelson and Mahajan, Aayushi and Nguyen, Trang and Jakubiak, Kelly A and Mun, Jeong-Yeon and Tedesco, Thomas G and Al-Dalahmah, Osama and Hussaini, Syed A and Sproul, Andrew A and Siegelin, Markus D and De Jager, Philip L and Canoll, Peter and Menon, Vilas and Hargus, Gunnar},
title = {Xenografted human iPSC-derived neurons with the familial Alzheimer’s disease APPV717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator},
journal = {Acta Neuropathologica},
year = {2024},
volume = {147},
number = {1},
doi = {10.1007/s00401-024-02755-5}
}
EUVIMED